Publications.png
 

Publications


Meeting Reports

Dallmann J, Freitag J, Jung C, Khinvasara K, Merz L, Peters D, Schork M, Beck JD CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy. Immuno-Oncology and Technology, DOI: 10.1016/j.iotech.2023.100397

Berger, AB, Freitag J, Linkenbach S, Merz L, Schork M, Thevissen S, Yildiz I & Beck J CIMT 2022: Report on the 19th Annual Meeting of the Assocation for Cancer Immunotherapy. Human Vaccines & Immunotherapeutics, DOI: 10.1080/21645515.2022.2124785

Billmeier A, Khinvasara K, Lang F, Mohr J, Reidenbach D, Schork M, Yildiz I & Diken M (2022) CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy, Human Vaccines & Immunotherapeutics, DOI: 10.1080/21645515.2021.2024416

Diken M, Kepp O, Brodsky AN Translating Science into Survival: Report on the Fifth International Cancer Immunotherapy Conference. Cancer Immunology Research. 2020. DOI: 10.1158/2326-6066.CIR-19-0888

Beck J, Birtel M, Haefner E, Keil IS,Reidenbach D, Salomon N, Yildiz I & Diken M CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy. Human Vaccines & Immunotherapeutics. DOI: 10.1080/21645515.2019.1675459

Jan Beck, Matthias Birtel, Daniel Reidenbach, Nadja Salomon & Mustafa Diken (2018) CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy, Human Vaccines & Immunotherapeutics, DOI: 10.1080/21645515.2018.1504526 

Diken M, Chu KK, Brodsky AN. Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference. Cancer Immunol. Res. 2018. 6:10-13. DOI. PMID.

Kranz LM, Birtel M, Hilscher L, Grunwitz C, Petschenka J, Vascotto F, Vormehr M, Voss RH, Kreiter S, Diken M. CIMT 2016: Mechanisms of efficacy in cancer research – Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy. May 10-12, 2016, Mainz, Germany. Hum. Vaccin. Immunother. 2016. 12:2805-12. DOI. PMID.

Miller M, Jahndel V, Kutscher S, Mahr A, Rae R, Kloke BP. The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11-13, 2015. Cancer Immunol. Immunother. 2016. 65:1277-87. DOI. PMID.

Kranz L,  Birtel M, Krienke C, Grunwitz C, Petschenka J,  Reuter K, van de Roemer N, Vascotto F, Vormehr M, Kreiter S, Diken M. CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy. Hum. Vaccin. Immunother. 2015. 12:213-21. DOI. PMID.

Diken M, Boegel S, Grunwitz C, Kranz L, Reuter K, van de Roemer N, Vascotto F, Vormehr M, Kreiter S. CIMT 2014: Next waves in cancer immunotherapy - report on the 12th annual meeting of the Association for Cancer Immunotherapy. Hum. Vaccin. Immunother. 2015. 10:3090-100. DOI. PMID.

Kloke BP, Mahr A, Jabulowsky RA, Kutscher S, Rae R, Britten CM. Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014. Cancer Immunol. Immunother. 2014. 64:923-30. DOI. PMID.

Kloke BP, Rae R, Mahr A, Burkhardt UE, Kvistborg P, Britten CM. Towards the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013. Cancer Immunol. Immunother. 2013. 63:749-55. DOI. PMID.

Diken M, Attig S, Grunwitz C, Kranz L, Simon P, van de Roemer N, Vascotto F, Kreiter S. Advancing targeted therapies—report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14–16 2013, Mainz, Germany. Human Vaccin. Immunother. 2013.  9: 2025–32.  DOI. PMID.

Kloke BP, Kutscher S, Rae R, Kvistborg P, Britten CM, Hadrup SR. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012. Cancer Immunol. Immunother. 2013. 62:975-81. DOIPMID

Hobohm K, Seppmann T, Britten CM, Hoff H. Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany. Cancer Immunol. Immunother. 2012. 61:137-43. DOI. PMID.

Singh SK, Laske K, Gouttefangeas C, Britten CM, Welters MJ. CIMT 2010: report on the eighth annual meeting of the Association for Cancer Immunotherapy, May 26-28, 2010, Mainz, Germany. Cancer Immunol. Immunother. 2011. 60:443-50. DOI. PMID.

Diken M, Widenmeyer M, Gouttefangeas C, Welters MJ, Britten CM. CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany. Cancer Immunol. Immunother. 2010. 59:1417-23. DOI. PMID.

Welters MJ, van Montfoort N, Khan S, Meyer RG, Britten CM. Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany. Cancer Immunol. Immunother. 2009. 58:777-87. DOI. PMID.

Welters MJ, Gouttefangeas C, Attig S, Koch S, Britten CM. Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12-14, 2007 in Würzburg, Germany. Cancer Immunol. Immunother. 2008. 57:135-42. DOI. PMID.

Gouttefangeas C, Britten CM, Badalians ED, Pawelec G. CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006. Cancer Immunol. Immunother. 2007. 56:397-427. DOI. PMID.

Britten CM, Gouttefangeas C, Kreiter S. Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005. Cancer Immunol. Immunother. 2006. 55:475-80. DOI. PMID.

Britten CM, Mueller L, Knights A, Pawelec G. Cancer Immunotherapy 2004: Mainz, Germany, 6-7 May 2004. Cancer Immunol. Immunother. 2004. 53:1153-8. DOI. PMID.



CIMT and CIMT Immunoguiding Program (CIP) Publications

Please see www.cimt.eu/publications-1/.



CIMT-RRG Publications

Jan Beck, Matthias Birtel, Daniel Reidenbach, Nadja Salomon & Mustafa Diken (2018) CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy, Human Vaccines & Immunotherapeutics, DOI: 10.1080/21645515.2018.1504526  Please see https://www.cimt.eu/rrg-2